[citation needed] The firm, founded in 1995, is based in Hopkinton, Massachusetts, with direct sales, service and application-support operations in countries around the globe.
[1] Caliper researched and produced microfluidic lab-on-a-chip technology, used for drug screening and profiling and for DNA, RNA and protein analysis.
In 2003, the firm acquired Zymark, a company with a focus in laboratory automation and robotics, and was renamed Caliper Life Sciences.
In October 2005, it acquired NovaScreen Biosciences Corporation a privately held CRO offering pre-clinical drug discovery and development services.
[10] On November 7, 2011, PerkinElmer completed the acquisition of Caliper Life Sciences for a total net purchase price of approximately $600 million in cash.